Durata Therapeutics, Inc. Accounts Receivable
Durata Therapeutics, Inc. had Accounts Receivable of $192.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2014-11-07
- 2014-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $192.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2014-09-30 | $192.00K 10-Q · filed 2014-11-07 |